Phosphodiesterase 4 Inhibition in the Management of Psoriasis
Erika L. Crowley(University of British Columbia), Melinda Gooderham(Queen's University)
Cited by 5
Related Papers
Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic Dermatitis
|JAMA Dermatology|2019|505
Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: A randomized, double-blinded, placebo-controlled phase 3 trial
|Journal of the American Academy of Dermatology|2020|385
Phosphodiesterase-4 Inhibition in the Management of Psoriasis
|Pharmaceutics|2023|36